Impact of quercetin in patients with myocardial infarction. A multicenter, randomized, open label pilot study

CONCLUSION: Our pilot study is the first to demonstrate novel insight into ischemia/reperfusion damage in STEMI patients. The addition of quercetin to standard STEMI therapy limits infarct size and prevents intramyocardial hemorrhage after the first anterior STEMI. Further research will be necessary to both validate and expand upon these findings.PMID:37567562 | DOI:10.1016/j.hjc.2023.08.004

Source: Hellenic Journal of Cardiology - August 11, 2023 Category: Cardiology Authors: Sergey Kozhukhov Parkhomenko Alexander Yaroslav Lutay Nataliia Dovganych study investigator Source Type: research